Fig. 2From: Priorities when deciding on participation in early-phase gene therapy trials for Duchenne muscular dystrophy: a best–worst scaling experiment in caregivers and adult patientsPlot showing relative importance hierarchy for participating in a gene therapy clinical trial. Estimates are odds ratios from the final conditional logit model. The black bars are estimates for which no interaction by participant subgroup was found and represent the average relative importance across all participants. The grey and white bars are importance estimates for “chance of improved lung function” among participants in each subgroup. Error bars represent the 95% confidence intervals for odds ratios. Muscle benefit is the reference category, constrained to equal 1Back to article page